Prostate Cancer Therapeutics Market by Product Type (Hormonal Therapy [Luteinizing Hormone-releasing Hormone (LHRH) Analogs, Luteinizing Hormone-releasing Hormone (LHRH) Antagonists, and Anti-androgens], Chemotherapy, Targeted Therapy, and Immunotherapy) and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Global prostate cancer therapeutics market expected to generate revenue of around USD 17,200 million by end of 2024, growing at a CAGR of around 8% between 2018 and 2024. The uncontrolled growth of prostate gland cells leads to prostate cancer. In the U.S., prostate cancer is the one of most common cancer after skin cancer in men.

Request Brochure Request Discount

21-Sep-2018 | Number of pages: 130 | Report Code: ZMR-2320 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the prostate cancer therapeutics market on a global and regional level. The study provides historic data of 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the prostate cancer therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the prostate cancer therapeutics market on a global level.

In order to give the users of this report a comprehensive view of the prostate cancer therapeutics market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein the product type and distribution channel are benchmarked based on their market size, growth rate, and general attractiveness.

Global Prostate Cancer Therapeutics Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research& development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

The study provides a decisive view of the prostate cancer therapeutics market by segmenting the market based on product type, distribution channel, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. Based on product type, the prostate cancer therapeutics market is segmented into hormonal therapy, chemotherapy, targeted therapy, and immunotherapy. The hormone therapy is further segmented as luteinizing hormone-releasing hormone (LHRH) analogs, luteinizing hormone-releasing hormone (LHRH) antagonists, and anti-androgens. Based on chemotherapy, the prostate cancer market is segregated as Jevtana, Mitoxantrone, Taxotere, Estramustine, and others agents. Based on the distribution channel, the market is segmented as a hospital pharmacy, retail pharmacy, and online pharmacy. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East & Africa with its further divided into major countries including the U.S., Rest of North America, U.K., Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, Brazil, Rest of Latin America, GCC Countries, South Africa and Rest of Middle East and Africa. This segmentation includes demand for prostate cancer therapeutics market based on individual product type and distribution channel in all the regions and countries.

The report also includes detailed profiles of end players such as are Amgen, Inc., Pfizer, Inc., Johnson & Johnson, AbbVie, Inc., AstraZeneca, Bayer AG, Sanofi, Ipsen Group, Dendreon Corporation, and Endo Pharmaceuticals, Inc.

This report segments the global Prostate cancer therapeutics market as follows:

Global Prostate Cancer Therapeutics Market: Product Type Segment Analysis

  • Hormonal Therapy
    • Luteinizing Hormone-releasing Hormone (LHRH) Analogs
      • Zoladex 
      • Lupron 
      • Eligard 
      • Decapeptyl 
      • Others 
    • Luteinizing Hormone-releasing Hormone (LHRH) Antagonists
    • Anti-androgens
  • Chemotherapy 
    • Jevtana
    • Mitoxantrone
    • Taxotere
    • Estramustine
    • Others 
  • Targeted Therapy 
  • Immunotherapy

Global Prostate Cancer Therapeutics Market: End-User Segment Analysis

  • Hospital Pharmacy Pharmacy
  • Retail Pharmacy
  • Online Pharmacy 

Global Prostate Cancer Therapeutics Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Pain Management Therapeutics Market by Drug Class (Anesthetics, NSAIDS, Anticonvulsants, Antidepressants, Anti-migraine agents, Non-narcotic Analgesics, and Opioids (Tramadol, Oxycodone, Hydrocodone, and Others)); by Indication (Neuropathic Pain, Arthritic Pain, Cancer Pain, Post-operative Pain, Chronic Back Pain, Fibromyalgia, and Migraine), and by Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Sep-2018 | Price : $ 4899.00 | Pages: 130 | Report Code: ZMR-3373 | Report Format:

The report covers forecast and analysis for the pain management therapeutics market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the pa...Read More

Healthcare Regulatory Affairs Outsourcing Market by Services (Regulatory Writing and Publishing, Regulatory Submissions, Clinical Trial Applications and Services Registrations, Regulatory Consulting and Legal Representation, and Other Regulatory Affairs) and by End-User (Mid-Size Pharmaceutical Companies, Large Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, and Food and Beverage Companies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3369 | Report Format:

The report covers forecast and analysis for the healthcare regulatory affairs outsourcing market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints fo...Read More

Thrombosis Drug Market by Drug Class (Factor Xa Inhibitor, Low Molecular Weight Heparin, and P2Y12 Platelet Inhibitor), by Indications (Pulmonary Embolism, Atrial Fibrillation, and Deep Vein Thrombosis), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017- 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3363 | Report Format:

The report covers forecast and analysis for the thrombosis drug market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the thrombosis drug market along...Read More

Artificial Intelligence in Diabetes Management Market by Device (Glucose Monitoring Devices, Diagnostic Devices, Insulin Delivery Devices, and Other Devices) and by Technique Type (Case-based Reasoning and Intelligent Data Analysis): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024

Sep-2018 | Price : $ 4899.00 | Pages: 160 | Report Code: ZMR-3361 | Report Format:

The report covers forecast and analysis for the artificial intelligence in diabetes management market on a global and regional level. The study provides historical data from 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and ...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.